|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
2.130 -0.035 (-1.617%) | 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Turnover | 171,423 | 3.594% | 365,347 | 349,112 | 359,292 | 354,480 |
| Cost of Sales | (74,204) | 12.211% | (150,203) | (132,432) | (139,767) | (152,254) |
| Gross Profit | 97,219 | -2.142% | 215,144 | 216,680 | 219,525 | 202,226 |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (77) | -34.746% | 210 | 30 | (421) | (521) | |
| Profit / (Loss) before Taxation | 2,258 | -80.850% | 28,550 | 32,541 | 37,130 | 44,242 | |
| Taxation | (1,205) | -57.026% | (3,545) | (3,775) | (4,232) | (4,162) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,208) | -13.784% | (5,989) | (3,640) | (1,399) | 90 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,155) | -- | 19,016 | 25,126 | 31,499 | 40,170 | |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Net Finance Costs / (Income) | 1,882 | 60.992% | 2,284 | 1,139 | 1,842 | 1,359 |
| Depreciation & Amortisation | 10,930 | 27.034% | 17,349 | 17,306 | 14,235 | 12,402 |
| Directors' Emoluments | -- | -- | 1,881 | 1,403 | 1,681 | 2,565 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.250 | -- | 4.060 | 5.360 | 6.740 | 8.620 |
| DPS (cts) | 0.000 | -- | 1.213 | 1.622 | 2.020 | 2.204 |
| Dividend Payout Ratio (%) | -- | -- | 29.875% | 30.257% | 29.973% | 25.574% |
| Cash flow per share ($) | -- | -- | 0.020 | 0.071 | 0.094 | 0.047 |
| NBV per share ($) | 1.014 | -- | 1.025 | 0.991 | 0.966 | 0.922 |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -1,155 |
| %Change | -- |
| EPS / (LPS) | USD -0.003 |
| NBV Per Share ($) | USD 1.014 |